期刊文献+

陕西省细菌耐药监测网2014—2016年革兰阳性菌耐药性监测 被引量:5

Surveillance on antimicrobial resistance of gram-positive bacteria in Shaanxi Provincial Bacterial Resistance Surveillance Network from 2014 to 2016
在线阅读 下载PDF
导出
摘要 目的分析2014—2016年陕西省细菌耐药监测网革兰阳性菌耐药率变化情况,为革兰阳性菌感染的治疗提供理论依据。方法收集2014—2016年陕西省细菌耐药监测网各成员医院革兰阳性菌数据,依据美国临床实验室标准化协会(CLSI)2016年标准,采用WHONET 5.6软件进行数据分析。结果共收集陕西省耐药监测网42所入网医院数据。2014—2016年各年份分别收集细菌43 830、48 258、61 819株,其中革兰阳性菌分别为14 487株(33.1%)、15 303株(31.7%)和18 613(30.1%)株。革兰阳性菌来源居前5位的标本分别为痰(14 844株,30.7%)、血(8 873株,18.3%)、分泌物(6 271株,13.0%)、尿(5 225株,10.8%)和伤口脓液(2 449株,5.0%)。分离前三位的革兰阳性菌属分别为葡萄球菌属(28 878株,占59.7%)、肠球菌属(10 207株,21.1%)和链球菌属(8 824株,18.2%)。2014—2016年,耐甲氧西林金黄色葡萄球菌(MRSA)检出率分别为36.1%、45.2%和38.6%,耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)的检出率分别为80.5%、81.0%和83.3%,未发现耐万古霉素、利奈唑胺和替考拉宁的葡萄球菌属细菌;粪肠球菌对万古霉素耐药率分别为1.7%、0.8%和0.7%,屎肠球菌对万古霉素耐药率分别为3.1%、2.0%和2.1%;非脑脊液分离的肺炎链球菌中,耐青霉素肺炎链球菌(PRSP)的检出率分别为11.8%、6.1%和4.7%。结论本地区临床分离革兰阳性菌耐药现象较为普遍,应加强对细菌耐药的监测及管理,及时了解细菌耐药情况,为临床合理用药提供依据。 Objective To analyze the change in antimicrobial resistance rate of gram-positive bacteria in Shaanxi Provincial Bacterial Resistance Surveillance Network(BRSN)from 2014 to 2016,and provide theoretical basis for treatment of gram-positive bacterial infection.Methods Data of gram-positive bacteria from participating hospitals in Shaanxi Provincial BRSN between 2014 and 2016 were collected,according to 2016 standards of American Clinical and Laboratory Standards Institute(CLSI),data were analyzed with WHONET 5.6 software.Results Data of 42 participating hospitals in Shaanxi Provincial BRSN were collected.43 830,48 258,and 61 819 strains of bacteria were collected in each year from 2014 to 2016,of which gram-positive bacteria were 14 487(33.1%),15 303(31.7%),and 18 613(30.1%)respectively.The top 5 specimens of gram-positive bacteria were sputum(n=14 844,30.7%),blood(n=8 873,18.3%),secretion(n=6 271,13.0%),urine(n=5 225,10.8%),and wound pus(n=2 449,5.0%).The top three gram-positive bacteria were Staphylococcus spp.(n=28 878,59.7%),Enterococcus spp.(n=10 207,21.1%),and Streptococcus spp.(n=8 824,18.2%).From 2014 to 2016,isolation rates of methicillin-resistant Staphylococcus aureus(MRSA)were 36.1%,45.2%,and 38.6%respectively,isolation rates of methicillin-resistant coagulase negative Staphylococcus(MRCNS)were 80.5%,81.0%,and 83.3%respectively,vancomycin-,linezolid-,and teicoplanin-resistant Staphylococcus spp.were not found;resistance rates of Enterococcus faecalis to vancomycin were 1.7%,0.8%,and 0.7%,respectively,resis-tance rates of Enterococcus faecium to vancomycin were 3.1%,2.0%,and 2.1%respectively;among Streptococcus pneumoniae isolated from non-cerebrospinal fluid,isolation rates of penicillin-resistant Streptococcus pneumoniae(PRSP)in three years were 11.8%,6.1%,and 4.7%respectively.Conclusion Antimicrobial resistance of clinically isolated gram-positive bacteria is more common in this region,surveillance and management of bacterial resis-tance should be strengthened,antimicrobial resistance of bacteria should be realized in time,so as to provide basis for rational clinical antimicrobial use.
作者 归巧娣 范芸 任健康 宫艳艳 GUI Qiao-di;FAN Yun;REN Jiang-kang;GONG Yan-yan(Shaanxi Provincial People’s Hospital,Xi’an 710068,China)
机构地区 陕西省人民医院
出处 《中国感染控制杂志》 CAS 北大核心 2018年第9期823-826,共4页 Chinese Journal of Infection Control
关键词 革兰阳性菌 耐药性 监测 抗菌药物 gram-positive bacteria bacterial resistance surveillance antimicrobial agent
作者简介 通信作者:归巧娣(1978-),女(汉族),河北省青县人,副主任医师,主要从事临床微生物检验及耐药性分析研究。E-mail:gqd1212@126.com。
  • 相关文献

参考文献11

二级参考文献87

  • 1李家泰,李耘,齐慧敏,代表中国细菌耐药监测研究组.2002—2003年中国革兰阴性细菌耐药性监测研究[J].中华检验医学杂志,2005,28(1):19-29. 被引量:296
  • 2李家泰,齐慧敏,李耘,代表中国细菌耐药监测研究组.2002—2003年中国医院和社区获得性感染革兰阳性细菌耐药监测研究[J].中华检验医学杂志,2005,28(3):254-265. 被引量:225
  • 3Biedenbach D J, Bell JM, Sader HS, et al. Antimicrobial susceptibility of Gram - positive bacterial isolates from the Asia - Pacific region and in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004) [J]. Int J Antimicrob Agents, 2007; 30:143 - 149.
  • 4Turmer PJ. MYSTIC Europe 2007 : Activity of meropenem and other broadspectrum agents against nosocomial isolates [ J ]. Diagn Microbiol Infect Dis, 2009; 63:217-222.
  • 5Jones RN, Kirby JT, Rhomberg PR. Comparative activity of meropenem in US medical centers (2007) : Initiating the 2nd decade of MYSTIC program surveillance [ J ]. Diagn Microbiol Infect Dis, 2008; 61 : 203 -213.
  • 6Oteo J, Cuevas O, Navarre C, et al. Trends in antimicrobial resistance in 3469 enterococci isolated from blood (EARSS experience 2001 -06, Spain) : Increasing ampicillin resistance in Enterococcus faecium [ J ]. J Antimicrob Chemother, 2007 ; 21 : 1044 - 1045.
  • 7Bouchillon SK, Iredell JR, Barkham T, et al. Comparative in vitro activity of tigecycline and other antimicrobials against Gram - negative and Gram - positive organisms collected from the Asia - Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST) [J]. Int J Antimicrob Agents,2009; 33:130 -136.
  • 8Inoue M, Farrell D J, Kaneko K, et al. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1 - 5 ( 1999 - 2004) [ J ]. Microb Drug Resist, 2008 ; 14 : 109 - 117.
  • 9Clinical and Laboratory Standard Institute.Performance standardsfor antimicrobial susceptibility testing;nineteenth informationalsupplement[S].Wayne:Clinical and Laboratory Standards Insti-tute,2010.
  • 10Xi Zhu,B.Zheng,S Wang,et al.Molecular characterizationof outbreak-related strains of vancomycin-resistant Enterococ-cus faeciumfrom an intensive care unit in Beijing[J].Chin JHosp Infec,2010,72(2):147-154.

共引文献1236

同被引文献36

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部